首页 > 最新文献

Journal of global antimicrobial resistance最新文献

英文 中文
Antimicrobial utilization among hospitalized patients according to WHO AWaRe classification: Results from a multicentre point prevalence survey in Saudi Arabia 根据世卫组织认知分类,住院患者抗菌药物使用情况:沙特阿拉伯多中心点流行病学调查结果。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-24 DOI: 10.1016/j.jgar.2025.09.009
Nada A. Alsaleh , Abeer AlSmari , Abrar F. Alhameed , Ahmed O. Alenazi , Alaa A. Alsharif , Amal Bin Akresh , Anwar M. Alnakhli , Bashaier Alshehail , Eman A. Alzahrani , Ghadah H. Alshehri , Ghazwa B. Korayem , Hanan A. Bakri , Khalid Eljaaly , Lina I. Alnajjar , Norah S. Aldeghaither , Reem Almahasna , Sara Almuhisen , Yassmin Alsomali , Zikria Saleem

Background

Antimicrobial resistance (AMR) threatens global health by reducing the efficacy of common infection treatments. This study examines antimicrobial use in Saudi Arabian hospitals, identifies influencing factors, and proposes interventions using the World Health Organization’s (WHO) Access, Watch, Reserve (AWaRe) classification system.

Methods

A cross-sectional, multicentre point prevalence survey (PPS) of antimicrobial utilization was conducted in 10 hospitals across 6 regions of Saudi Arabia September 2023. All inpatients receiving antimicrobials on the PPS day were included. Data collection utilized the Global PPS tool developed by the University of Antwerp, Belgium.

Results

Among 2890 inpatients, 766 (26.5%) were prescribed at least one antimicrobial, resulting in a total of 982 prescriptions. The primary indications for these antimicrobials were community-acquired infections (37.1%), Healthcare-associated infections (35.9%), surgical prophylaxis (15.4%), unknown reasons (8.7%), medical prophylaxis (2.5%), and other reasons (0.3%). The most common reasons for antimicrobial use included pneumonia or lower respiratory tract infections (16.1%), skin and soft tissue infections (11%) and bacteraemia (8.9%). The most frequently prescribed antimicrobial classes were penicillins with beta-lactamase inhibitors (18.5%), carbapenems (15.7%), and third-generation cephalosporins (11.1%). Most of the antimicrobials (66.3%) were classified as Watch antimicrobials, followed by 23.8% as Access, and 8.9% as Reserve.

Conclusions

The study provides valuable insights into antimicrobial utilization in Saudi Arabia, offering a baseline for assessing prescribing patterns. While findings may reflect certain antimicrobial stewardship efforts, further investigation is needed to evaluate their impact. The study also highlights key areas for improvement, emphasizing the importance of conducting future PPS to guide antimicrobial stewardship strategies and monitor progress in managing AMR.
背景:抗菌素耐药性(AMR)通过降低常见感染治疗的有效性来威胁全球健康。本研究调查了沙特阿拉伯医院的抗菌药物使用情况,确定了影响因素,并使用世界卫生组织(WHO)的获取、观察、储备(AWaRe)分类系统提出了干预措施。方法:于2023年9月对沙特阿拉伯6个地区10家医院的抗菌药物使用情况进行横断面多中心点流行病学调查(PPS)。所有在PPS日接受抗微生物药物治疗的住院患者均被纳入。数据收集利用了比利时安特卫普大学开发的全球PPS工具。结果:2890例住院患者中,766例(26.5%)至少使用了一种抗菌药物,共使用982张处方。这些抗菌素的主要适应症为社区获得性感染(37.1%)、卫生保健相关感染(35.9%)、手术预防(15.4%)、不明原因(8.7%)、医学预防(2.5%)和其他原因(0.3%)。使用抗微生物药物的最常见原因包括肺炎或下呼吸道感染(16.1%)、皮肤和软组织感染(11%)和菌血症(8.9%)。最常用的抗菌药物是含β -内酰胺酶抑制剂的青霉素(18.5%)、碳青霉烯类(15.7%)和第三代头孢菌素(11.1%)。大多数抗菌药物(66.3%)被归类为观察类抗菌药物,其次是23.8%的可获得类抗菌药物,8.9%为储备类抗菌药物。结论:该研究为沙特阿拉伯的抗菌药物使用提供了有价值的见解,为评估处方模式提供了基线。虽然研究结果可能反映了某些抗菌药物管理工作,但需要进一步调查以评估其影响。该研究还强调了需要改进的关键领域,强调了开展未来PPS以指导抗菌素管理战略和监测抗生素耐药性管理进展的重要性。
{"title":"Antimicrobial utilization among hospitalized patients according to WHO AWaRe classification: Results from a multicentre point prevalence survey in Saudi Arabia","authors":"Nada A. Alsaleh ,&nbsp;Abeer AlSmari ,&nbsp;Abrar F. Alhameed ,&nbsp;Ahmed O. Alenazi ,&nbsp;Alaa A. Alsharif ,&nbsp;Amal Bin Akresh ,&nbsp;Anwar M. Alnakhli ,&nbsp;Bashaier Alshehail ,&nbsp;Eman A. Alzahrani ,&nbsp;Ghadah H. Alshehri ,&nbsp;Ghazwa B. Korayem ,&nbsp;Hanan A. Bakri ,&nbsp;Khalid Eljaaly ,&nbsp;Lina I. Alnajjar ,&nbsp;Norah S. Aldeghaither ,&nbsp;Reem Almahasna ,&nbsp;Sara Almuhisen ,&nbsp;Yassmin Alsomali ,&nbsp;Zikria Saleem","doi":"10.1016/j.jgar.2025.09.009","DOIUrl":"10.1016/j.jgar.2025.09.009","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) threatens global health by reducing the efficacy of common infection treatments. This study examines antimicrobial use in Saudi Arabian hospitals, identifies influencing factors, and proposes interventions using the World Health Organization’s (WHO) Access, Watch, Reserve (AWaRe) classification system.</div></div><div><h3>Methods</h3><div>A cross-sectional, multicentre point prevalence survey (PPS) of antimicrobial utilization was conducted in 10 hospitals across 6 regions of Saudi Arabia September 2023. All inpatients receiving antimicrobials on the PPS day were included. Data collection utilized the Global PPS tool developed by the University of Antwerp, Belgium.</div></div><div><h3>Results</h3><div>Among 2890 inpatients, 766 (26.5%) were prescribed at least one antimicrobial, resulting in a total of 982 prescriptions. The primary indications for these antimicrobials were community-acquired infections (37.1%), Healthcare-associated infections (35.9%), surgical prophylaxis (15.4%), unknown reasons (8.7%), medical prophylaxis (2.5%), and other reasons (0.3%). The most common reasons for antimicrobial use included pneumonia or lower respiratory tract infections (16.1%), skin and soft tissue infections (11%) and bacteraemia (8.9%). The most frequently prescribed antimicrobial classes were penicillins with beta-lactamase inhibitors (18.5%), carbapenems (15.7%), and third-generation cephalosporins (11.1%). Most of the antimicrobials (66.3%) were classified as Watch antimicrobials, followed by 23.8% as Access, and 8.9% as Reserve.</div></div><div><h3>Conclusions</h3><div>The study provides valuable insights into antimicrobial utilization in Saudi Arabia, offering a baseline for assessing prescribing patterns. While findings may reflect certain antimicrobial stewardship efforts, further investigation is needed to evaluate their impact. The study also highlights key areas for improvement, emphasizing the importance of conducting future PPS to guide antimicrobial stewardship strategies and monitor progress in managing AMR.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 147-156"},"PeriodicalIF":3.2,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145176153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance” [Journal of Global Antimicrobial Resistance 38 (2024) 12–20] “头孢地罗对日本耐药细菌监测中收集的产碳青霉烯酶和美罗培烯不敏感革兰氏阴性菌的体外活性”[Journal of Global Antimicrobial Resistance 38(2024) 12-20]的勘误表。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-24 DOI: 10.1016/j.jgar.2025.08.001
Shizuo Kayama, Sayoko Kawakami, Kohei Kondo, Norikazu Kitamura, Liansheng Yu, Wataru Hayashi, Koji Yahara, Yo Sugawara, Motoyuki Sugai
{"title":"Corrigendum to “In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance” [Journal of Global Antimicrobial Resistance 38 (2024) 12–20]","authors":"Shizuo Kayama,&nbsp;Sayoko Kawakami,&nbsp;Kohei Kondo,&nbsp;Norikazu Kitamura,&nbsp;Liansheng Yu,&nbsp;Wataru Hayashi,&nbsp;Koji Yahara,&nbsp;Yo Sugawara,&nbsp;Motoyuki Sugai","doi":"10.1016/j.jgar.2025.08.001","DOIUrl":"10.1016/j.jgar.2025.08.001","url":null,"abstract":"","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 68-69"},"PeriodicalIF":3.2,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145149389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Southeast‑Asian landscape of antimicrobial resistance research (2014–2024): A bibliometric analysis 东南亚抗菌素耐药性研究概况(2014-2024):文献计量学分析。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-20 DOI: 10.1016/j.jgar.2025.09.004
Alex S. Borromeo , Allan M. Manaloto , Ronilo P. Antonio

Objective

This study aimed to map the Southeast-Asian research landscape on antimicrobial resistance (AMR) using bibliometric techniques to identify thematic trends, intellectual structures, and research gaps.

Methods

A total of 1,989 Scopus-indexed articles published between 2014 and 2024 (mean citations = 17.33 per document) were analyzed using VOSviewer (v 1.6.20). Bibliographic cleaning and preprocessing were conducted in Microsoft Excel. Co-citation analysis identified influential publications and intellectual domains, while co-word analysis revealed thematic clusters and keyword co-occurrence patterns.

Results

AMR publications in Southeast Asia increased steadily, peaking in 2024 with more than 320 articles. The four co-citation clusters represented (1) global AMR governance and risk framing, (2) genomic tools for resistance detection, (3) foodborne AMR and standardized laboratory protocols, and (4) phylogenomic tracking of resistance evolution. Co-word clusters highlighted diagnostic surveillance, sociodemographic patterns, One Health perspectives, and molecular epidemiology. Despite research growth, Southeast Asia remained underrepresented in highly cited studies and global policy dialogues.

Conclusions

Findings underscore the need for stronger integration of Southeast Asia into the global AMR agenda. Enhancing regional genomic surveillance, adapting global frameworks to local systems, and embedding AMR competencies in public health and nursing education are vital to advancing policy and capacity-building.
目的:本研究旨在利用文献计量学技术绘制东南亚抗菌素耐药性(AMR)研究格局。背景:尽管抗菌素耐药性的威胁越来越大,而且东南亚具有高风险的特点,但目前还没有全面的文献计量综合研究来考察抗菌素耐药性在诊断、基因组监测和政策框架等领域的研究轨迹,以及该地区不断变化的贡献。方法:在VOSviewer (v 1.6.20)中对1989篇以scopus为索引的文献(2014-2024年,平均被引次数 = 17.33篇/篇)进行分析。在Microsoft Excel中进行书目清理,没有使用其他映射工具(例如CiteSpace、BibExcel)。共引分析确定了有影响力的出版物和知识领域,而共词分析揭示了主题集群和关键词共现模式。结果:2014年至2024年,东南亚地区AMR发表量稳步增长,2024年达到峰值,超过320篇。这四个共被引集群包括(1)全球抗菌素耐药性治理和风险框架,(2)耐药性检测的基因组工具,(3)食源性抗菌素耐药性和标准化实验室方案,以及(4)耐药性进化的系统基因组追踪。四个共词聚类揭示了诊断监测、社会人口模式、同一健康观点和分子流行病学方面的重点领域。尽管有这种增长(共1989篇文章),东南亚的研究在人畜共患抗菌素耐药性监测和基因组研究中发挥了突出作用,但在高被引出版物和具有全球影响力的政策讨论中仍然代表性不足。结论:研究结果强调了将东南亚公平纳入全球抗菌素耐药性议程的必要性。加强区域基因组监测,使全球框架适应地方系统,以及将抗微生物药物耐药性能力纳入公共卫生和护理教育,对于推进政策和能力建设至关重要。
{"title":"Southeast‑Asian landscape of antimicrobial resistance research (2014–2024): A bibliometric analysis","authors":"Alex S. Borromeo ,&nbsp;Allan M. Manaloto ,&nbsp;Ronilo P. Antonio","doi":"10.1016/j.jgar.2025.09.004","DOIUrl":"10.1016/j.jgar.2025.09.004","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to map the Southeast-Asian research landscape on antimicrobial resistance (AMR) using bibliometric techniques to identify thematic trends, intellectual structures, and research gaps.</div></div><div><h3>Methods</h3><div>A total of 1,989 Scopus-indexed articles published between 2014 and 2024 (mean citations = 17.33 per document) were analyzed using VOSviewer (v 1.6.20). Bibliographic cleaning and preprocessing were conducted in Microsoft Excel. Co-citation analysis identified influential publications and intellectual domains, while co-word analysis revealed thematic clusters and keyword co-occurrence patterns.</div></div><div><h3>Results</h3><div>AMR publications in Southeast Asia increased steadily, peaking in 2024 with more than 320 articles. The four co-citation clusters represented (1) global AMR governance and risk framing, (2) genomic tools for resistance detection, (3) foodborne AMR and standardized laboratory protocols, and (4) phylogenomic tracking of resistance evolution. Co-word clusters highlighted diagnostic surveillance, sociodemographic patterns, One Health perspectives, and molecular epidemiology. Despite research growth, Southeast Asia remained underrepresented in highly cited studies and global policy dialogues.</div></div><div><h3>Conclusions</h3><div>Findings underscore the need for stronger integration of Southeast Asia into the global AMR agenda. Enhancing regional genomic surveillance, adapting global frameworks to local systems, and embedding AMR competencies in public health and nursing education are vital to advancing policy and capacity-building.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 125-133"},"PeriodicalIF":3.2,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient 血液透析患者罕见的肺沃林斯基分枝杆菌感染。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-19 DOI: 10.1016/j.jgar.2025.09.006
Lin Zheng , Yanwan Shangguan , Wanru Guo , Zhongkang Ji , Kaijin Xu
In recent years, the detection rate of nontuberculous mycobacteria has increased, drawing attention in clinical settings. Here, we present a case of pulmonary Pseudomonas aeruginosa and Mycobacterium wolinskyi coinfection in a 60-year-old hemodialysis recipient. To the best of our knowledge, this is the first instance of isolating the M. wolinskyi strain from human respiratory samples, including a comprehensive exploration of its susceptibility to clinically available antimicrobials. This discovery deepened our understanding of the infection spectrum of M. wolinskyi, highlighting the need to consider the potential for coinfections with common pathogens and less common atypical pathogens when managing immunocompromised patients. Furthermore, this study also assessed the in vitro antibacterial activity of newly available antibacterial drugs in clinical practice against the M. wolinskyi strain.
近年来,非结核分枝杆菌的检出率有所提高,引起了临床的重视。在这里,我们提出一个病例肺铜绿假单胞菌和沃林斯基分枝杆菌合并感染在一个60岁的血液透析受者。据我们所知,这是首次从人类呼吸道样本中分离出沃林斯基支原体菌株,包括全面探索其对临床可用抗菌药物的敏感性。这一发现加深了我们对沃林斯基支原体感染谱的理解,强调在治疗免疫功能低下患者时需要考虑与常见病原体和不太常见的非典型病原体共感染的可能性。此外,本研究还评估了临床新开发的抗菌药物对沃林斯基支原体的体外抗菌活性。
{"title":"Uncommon pulmonary mycobacterium wolinskyi infection in a hemodialysis patient","authors":"Lin Zheng ,&nbsp;Yanwan Shangguan ,&nbsp;Wanru Guo ,&nbsp;Zhongkang Ji ,&nbsp;Kaijin Xu","doi":"10.1016/j.jgar.2025.09.006","DOIUrl":"10.1016/j.jgar.2025.09.006","url":null,"abstract":"<div><div>In recent years, the detection rate of nontuberculous mycobacteria has increased, drawing attention in clinical settings. Here, we present a case of pulmonary <em>Pseudomonas aeruginosa</em> and <em>Mycobacterium wolinskyi</em> coinfection in a 60-year-old hemodialysis recipient. To the best of our knowledge, this is the first instance of isolating the <em>M. wolinskyi</em> strain from human respiratory samples, including a comprehensive exploration of its susceptibility to clinically available antimicrobials. This discovery deepened our understanding of the infection spectrum of <em>M. wolinskyi</em>, highlighting the need to consider the potential for coinfections with common pathogens and less common atypical pathogens when managing immunocompromised patients. Furthermore, this study also assessed the in vitro antibacterial activity of newly available antibacterial drugs in clinical practice against the <em>M. wolinskyi</em> strain.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 134-137"},"PeriodicalIF":3.2,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population pharmacokinetics of imipenem in solid tumor patients with infections: A real-world study 亚胺培南在实体瘤感染患者中的群体药代动力学:一项现实世界研究。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-19 DOI: 10.1016/j.jgar.2025.09.005
Tingting Xu , Tingting Zou , Junyan Zhang , Zhuoran Li , Fangyu Li , Juan Du , Zhiying Hao

Objectives

To characterize the population pharmacokinetics (PPK) of imipenem in critically ill solid tumor patients and to optimize dosing regimens through pharmacodynamic analysis.

Methods

A PPK model was developed using nonlinear mixed-effects modeling (Monolix 2023R1) based on 25 critically ill solid tumor patients with infections. Model selection used objective function value (OFV), Akaike/Bayesian information criteria(AIC/BIC), and goodness-of-fit diagnostics. Covariate screening involved a dual-algorithm approach (SAMBA and COSSAC) for validation. Monte Carlo simulations (n=10,000) evaluated the probability of target attainment (PTA) for 100% fT>MIC across different renal function groups.

Results

A linear one-compartment model best described imipenem pharmacokinetics. Typical population estimates were clearance (CL) = 2.7 L/h and volume of distribution (Vd) = 10.6L—significantly lower than values reported in general critical care populations. Creatinine clearance (CLCR) and septic shock were identified as significant covariates affecting CL. Severe malnutrition contributed to reduced Vd. Simulations revealed: For MIC ≤2 mg·L⁻¹, 500 mg q6h achieved PTA >90% when CLCR >30 mL/min; for MIC = 4 mg·L⁻¹, 1000 mg q6h was required for patients with CLCR >60 mL/min (PTA = 94.9–100%); no regimen achieved PTA >20% for MIC ≥16 mg·L⁻¹.

Conclusion

This study highlights the significant effect of specific pathophysiological changes in solid tumor patients (such as cachexia-induced reduction in volume of distribution) on drug disposition, providing essential evidence for informing personalized imipenem dosing in this vulnerable group to improve efficacy and reduce resistance risks.
目的:研究亚胺培南在危重型实体瘤患者的群体药代动力学(PPK),并通过药效学分析优化给药方案。方法:采用非线性混合效应模型(Monolix 2023R1)建立25例感染重症实体瘤患者的PPK模型。模型选择采用目标函数值(OFV)、赤池/贝叶斯信息准则(AIC/BIC)和拟合优度诊断。协变量筛选涉及双算法方法(SAMBA和COSSAC)进行验证。蒙特卡罗模拟(n=10,000)评估了不同肾功能组100% fT>MIC的目标实现概率(PTA)。结果:线性单室模型最能描述亚胺培南的药代动力学。典型人群估计值为清除率(CL) = 2.7 L/h,分布体积(Vd) = 10.6L,显著低于一般重症监护人群报告的值。肌酐清除率(CLCR)和感染性休克被确定为影响CL的重要协变量。严重营养不良导致Vd降低。模拟显示:麦克风≤2 mg·L⁻¹,500毫克q6h实现PTA > 90% CLCR > 30毫升/分钟;对于MIC=4 mg·L -1, CLCR≤60 mL/min的患者需要1000 mg / h (PTA=94.9-100%);对于MIC≥16 mg·L的患者,没有任何一种治疗方案能达到20%的PTA毒血症。结论:本研究突出了实体瘤患者特异性病理生理变化(如恶病质诱导的分布体积减少)对药物配置的显著影响,为该弱势群体个体化亚胺培南给药以提高疗效、降低耐药风险提供了重要依据。
{"title":"Population pharmacokinetics of imipenem in solid tumor patients with infections: A real-world study","authors":"Tingting Xu ,&nbsp;Tingting Zou ,&nbsp;Junyan Zhang ,&nbsp;Zhuoran Li ,&nbsp;Fangyu Li ,&nbsp;Juan Du ,&nbsp;Zhiying Hao","doi":"10.1016/j.jgar.2025.09.005","DOIUrl":"10.1016/j.jgar.2025.09.005","url":null,"abstract":"<div><h3>Objectives</h3><div>To characterize the population pharmacokinetics (PPK) of imipenem in critically ill solid tumor patients and to optimize dosing regimens through pharmacodynamic analysis.</div></div><div><h3>Methods</h3><div>A PPK model was developed using nonlinear mixed-effects modeling (Monolix 2023R1) based on 25 critically ill solid tumor patients with infections. Model selection used objective function value (OFV), Akaike/Bayesian information criteria(AIC/BIC), and goodness-of-fit diagnostics. Covariate screening involved a dual-algorithm approach (SAMBA and COSSAC) for validation. Monte Carlo simulations (n=10,000) evaluated the probability of target attainment (PTA) for 100% fT&gt;MIC across different renal function groups.</div></div><div><h3>Results</h3><div>A linear one-compartment model best described imipenem pharmacokinetics. Typical population estimates were clearance (CL) = 2.7 L/h and volume of distribution (Vd) = 10.6L—significantly lower than values reported in general critical care populations. Creatinine clearance (CLCR) and septic shock were identified as significant covariates affecting CL. Severe malnutrition contributed to reduced Vd. Simulations revealed: For MIC ≤2 mg·L⁻¹, 500 mg q6h achieved PTA &gt;90% when CLCR &gt;30 mL/min; for MIC = 4 mg·L⁻¹, 1000 mg q6h was required for patients with CLCR &gt;60 mL/min (PTA = 94.9–100%); no regimen achieved PTA &gt;20% for MIC ≥16 mg·L⁻¹.</div></div><div><h3>Conclusion</h3><div>This study highlights the significant effect of specific pathophysiological changes in solid tumor patients (such as cachexia-induced reduction in volume of distribution) on drug disposition, providing essential evidence for informing personalized imipenem dosing in this vulnerable group to improve efficacy and reduce resistance risks.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 107-114"},"PeriodicalIF":3.2,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid sequencing of chromosome and plasmids from multidrug-resistant Escherichia coli isolated in Cambodia: Are megaplasmids vectors of antibiotic resistance genes? 柬埔寨多重耐药大肠杆菌的染色体和质粒杂交测序:巨质粒是抗生素耐药基因的载体吗?
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-17 DOI: 10.1016/j.jgar.2025.09.003
Ella Marcy , Sivhour Chiek , Mallorie Hidé , Savatey Hak , Chiva Ma , Meymey Lem , Gauthier Delvallez , Anne-Laure Bañuls , Sokleaph Cheng , Juliette Hayer

Objectives

The prevalence of antimicrobial resistance (AMR) in Escherichia coli infections in Cambodia is high and increasing, yet data distinguishing plasmid- and chromosome-mediated AMR spread remain limited. The aim of this study was to characterize chromosomal and plasmid structures in clinically relevant E. coli resistant strains to investigate mechanisms driving the spread of antibiotic resistance genes (ARGs) in Battambang Province, Cambodia.

Methods

Hybrid genome assembly was performed using short- and long-read sequencing of six extended–spectrum beta-lactamase (ESBL)- and carbapenemase–producing (CP) E. coli isolates collected from patients at Battambang Provincial Hospital, Cambodia. Detailed bacteriological analyses were conducted, as well as comprehensive genomic investigations to characterize sequence types (STs), plasmids, resistance mechanisms, and phylogenetic relationships among the strains and to perform pairwise comparisons of plasmid sequences.

Results

Chromosome and plasmid sequences were successfully recovered for each strain. Five STs were identified: ST1193 (two strains), ST131, ST205, ST405, and ST4204. All strains displayed a megaplasmid carrying ARGs, and one to five regular-sized plasmids without ARGs. Four distinct megasplasmid sequences were identified, including one shared by two ST1193 strains and one shared by ST131 and ST205 strains.

Conclusions

The identification of megaplasmids carrying ARGs and shared by different strains highlights their potential role in the spread of antimicrobial resistance through horizontal gene transfer in Cambodia. This study also confirms the circulation of the high-risk multidrug-resistant (MDR) clones ST131 and ST1193 in Battambang province, Cambodia, and underscores the importance of hybrid genome assembly to study plasmid structure and identify their role in AMR spread.
目的:柬埔寨大肠杆菌感染中抗菌素耐药性(AMR)的流行率很高,而且还在增加,但区分质粒和染色体介导的AMR传播的数据仍然有限。本研究的目的是表征临床相关大肠杆菌耐药菌株的染色体和质粒结构,以研究柬埔寨马德望省驱动抗生素耐药基因(ARGs)传播的机制。方法:对从柬埔寨马德望省医院患者身上收集的6株产β -内酰胺酶(ESBL)和产碳青霉烯酶(CP)大肠杆菌进行短读和长读测序,进行杂交基因组组装。进行了详细的细菌学分析,以及全面的基因组调查,以表征序列类型(STs),质粒,抗性机制和菌株之间的系统发育关系,并对质粒序列进行两两比较。结果:各菌株的染色体和质粒序列均成功恢复。共鉴定出5株STs: ST1193(2株)、ST131、ST205、ST405和ST4204。所有菌株均显示一个携带ARGs的巨型质粒,以及1 - 5个不携带ARGs的常规大小质粒。鉴定出4个不同的大质粒序列,其中1个为2株ST1193共有,1个为ST131和ST205共有。结论:携带ARGs并由不同菌株共享的巨质粒的鉴定突出了它们在柬埔寨通过水平基因转移(HGT)传播抗菌素耐药性中的潜在作用。本研究还证实了高风险多药耐药(MDR)克隆ST131和ST1193在柬埔寨马德望省的传播,并强调了杂交基因组组装对研究质粒结构和确定其在AMR传播中的作用的重要性。
{"title":"Hybrid sequencing of chromosome and plasmids from multidrug-resistant Escherichia coli isolated in Cambodia: Are megaplasmids vectors of antibiotic resistance genes?","authors":"Ella Marcy ,&nbsp;Sivhour Chiek ,&nbsp;Mallorie Hidé ,&nbsp;Savatey Hak ,&nbsp;Chiva Ma ,&nbsp;Meymey Lem ,&nbsp;Gauthier Delvallez ,&nbsp;Anne-Laure Bañuls ,&nbsp;Sokleaph Cheng ,&nbsp;Juliette Hayer","doi":"10.1016/j.jgar.2025.09.003","DOIUrl":"10.1016/j.jgar.2025.09.003","url":null,"abstract":"<div><h3>Objectives</h3><div>The prevalence of antimicrobial resistance (AMR) in <em>Escherichia coli</em> infections in Cambodia is high and increasing, yet data distinguishing plasmid- and chromosome-mediated AMR spread remain limited. The aim of this study was to characterize chromosomal and plasmid structures in clinically relevant <em>E. coli</em> resistant strains to investigate mechanisms driving the spread of antibiotic resistance genes (ARGs) in Battambang Province, Cambodia.</div></div><div><h3>Methods</h3><div>Hybrid genome assembly was performed using short- and long-read sequencing of six extended–spectrum beta-lactamase (ESBL)- and carbapenemase–producing (CP) <em>E. coli</em> isolates collected from patients at Battambang Provincial Hospital, Cambodia. Detailed bacteriological analyses were conducted, as well as comprehensive genomic investigations to characterize sequence types (STs), plasmids, resistance mechanisms, and phylogenetic relationships among the strains and to perform pairwise comparisons of plasmid sequences.</div></div><div><h3>Results</h3><div>Chromosome and plasmid sequences were successfully recovered for each strain. Five STs were identified: ST1193 (two strains), ST131, ST205, ST405, and ST4204. All strains displayed a megaplasmid carrying ARGs, and one to five regular-sized plasmids without ARGs. Four distinct megasplasmid sequences were identified, including one shared by two ST1193 strains and one shared by ST131 and ST205 strains.</div></div><div><h3>Conclusions</h3><div>The identification of megaplasmids carrying ARGs and shared by different strains highlights their potential role in the spread of antimicrobial resistance through horizontal gene transfer in Cambodia. This study also confirms the circulation of the high-risk multidrug-resistant (MDR) clones ST131 and ST1193 in Battambang province, Cambodia, and underscores the importance of hybrid genome assembly to study plasmid structure and identify their role in AMR spread.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 115-124"},"PeriodicalIF":3.2,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring of antimicrobial resistance in hospital, municipal, and treated wastewater in Mbarara, Uganda 监测乌干达姆巴拉拉医院、城市和处理过的废水中的抗菌素耐药性。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-16 DOI: 10.1016/j.jgar.2025.09.002
Claudia Stange , Rogers Kalyetsi , Judith Owokuhaisa , Moses Ntaro , Arthur Leon , Paul R. Hunter , Andreas Tiehm , Edgar M. Mulogo

Objective

The aim of this study was to estimate the prevalence of antimicrobial resistance in the population of Mbarara through analysis of wastewater and determine the effectiveness of wastewater treatment in reducing discharge of antibiotic-resistant bacteria and antibiotic resistance genes into the environment.

Methods

Hospital, municipal, and treated wastewater (collected on 10 different dates) from Mbarara, Uganda, were analysed for extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli using a culture-based method and selected clinically relevant antibiotic resistance genes using quantitative PCR.

Results

The finding of this study demonstrated that 30.6% of the total E. coli were ESBL producers, constituting a high proportion compared to studies in other countries. Furthermore, the investigation revealed the widespread distribution of the carbapenemase gene blaCMY-2 within the population. The comparative study of the inflow and outflow of the waste stabilisation pond system, which is used for wastewater treatment, demonstrated a log reduction of 1.9–2.4 for coliform bacteria and total as well as ESBL-producing E. coli. Conversely, the wastewater treatment was associated with an increase of the antibiotic resistance genes sul1 and tetC.

Conclusions

The study shows that the waste stabilisation pond system is releasing significant amounts of coliform bacteria, E. coli, ESBL-producing E. coli, somatic bacteriophages, and antibiotic resistance genes into the Rwizi River. We also demonstrated that wastewater-based surveillance is a cost-effective method of obtaining information on the prevalence of AMR in the population, especially in countries where clinical surveillance is limited due to a lack of resources and infrastructure.
目的:本研究的目的是通过对废水的分析来估计Mbarara人群中抗菌素耐药性的流行情况,并确定废水处理在减少抗生素耐药细菌和抗生素耐药基因排放到环境中的有效性。方法:采用基于培养的方法对乌干达姆巴拉拉的医院、市政和处理过的废水(收集于10个不同日期)进行分析,以检测产生广谱β -内酰胺酶(ESBL)的大肠杆菌,并使用定量PCR选择临床相关的抗生素耐药基因。结果:本研究结果表明,30.6%的大肠杆菌是ESBL生产者,与其他国家的研究相比,这一比例很高。此外,调查还揭示了碳青霉烯酶基因blaCMY-2在人群中的广泛分布。对用于废水处理的废物稳定池系统的流入和流出的对比研究表明,大肠菌群和总大肠杆菌以及产生esbl的大肠杆菌的对数降低了1.9至2.4。相反,废水处理与抗生素抗性基因sul1和tetC的增加有关。结论:研究表明,废物稳定池系统向瑞茨河释放了大量大肠菌群、大肠杆菌、产esble大肠杆菌、体细胞噬菌体和抗生素耐药基因。我们还证明,基于废水的监测是一种具有成本效益的方法,可以获得有关人群中抗菌素耐药性流行情况的信息,特别是在由于缺乏资源和基础设施而临床监测有限的国家。
{"title":"Monitoring of antimicrobial resistance in hospital, municipal, and treated wastewater in Mbarara, Uganda","authors":"Claudia Stange ,&nbsp;Rogers Kalyetsi ,&nbsp;Judith Owokuhaisa ,&nbsp;Moses Ntaro ,&nbsp;Arthur Leon ,&nbsp;Paul R. Hunter ,&nbsp;Andreas Tiehm ,&nbsp;Edgar M. Mulogo","doi":"10.1016/j.jgar.2025.09.002","DOIUrl":"10.1016/j.jgar.2025.09.002","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to estimate the prevalence of antimicrobial resistance in the population of Mbarara through analysis of wastewater and determine the effectiveness of wastewater treatment in reducing discharge of antibiotic-resistant bacteria and antibiotic resistance genes into the environment.</div></div><div><h3>Methods</h3><div>Hospital, municipal, and treated wastewater (collected on 10 different dates) from Mbarara, Uganda, were analysed for extended-spectrum beta-lactamase (ESBL)-producing <em>Escherichia coli</em> using a culture-based method and selected clinically relevant antibiotic resistance genes using quantitative PCR.</div></div><div><h3>Results</h3><div>The finding of this study demonstrated that 30.6% of the total <em>E. coli</em> were ESBL producers, constituting a high proportion compared to studies in other countries. Furthermore, the investigation revealed the widespread distribution of the carbapenemase gene <em>bla</em><sub>CMY-2</sub> within the population. The comparative study of the inflow and outflow of the waste stabilisation pond system, which is used for wastewater treatment, demonstrated a log reduction of 1.9–2.4 for coliform bacteria and total as well as ESBL-producing <em>E. coli</em>. Conversely, the wastewater treatment was associated with an increase of the antibiotic resistance genes <em>sul1</em> and <em>tet</em>C.</div></div><div><h3>Conclusions</h3><div>The study shows that the waste stabilisation pond system is releasing significant amounts of coliform bacteria, <em>E. coli</em>, ESBL-producing <em>E. coli</em>, somatic bacteriophages, and antibiotic resistance genes into the Rwizi River. We also demonstrated that wastewater-based surveillance is a cost-effective method of obtaining information on the prevalence of AMR in the population, especially in countries where clinical surveillance is limited due to a lack of resources and infrastructure.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 100-106"},"PeriodicalIF":3.2,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro evaluation of Ibrexafungerp against clinical and environmental isolates of cryptococcus neoformans and cryptococcus gattii Ibrexafungerp体外抗新型隐球菌和加蒂隐球菌临床和环境分离株的评价。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-11 DOI: 10.1016/j.jgar.2025.09.001
Andrés Ceballos-Garzon, Carolina Firacative
{"title":"In vitro evaluation of Ibrexafungerp against clinical and environmental isolates of cryptococcus neoformans and cryptococcus gattii","authors":"Andrés Ceballos-Garzon,&nbsp;Carolina Firacative","doi":"10.1016/j.jgar.2025.09.001","DOIUrl":"10.1016/j.jgar.2025.09.001","url":null,"abstract":"","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 84-85"},"PeriodicalIF":3.2,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-existence of mcr-1 and blaCTX−M from porcine-derived Escherichia coli isolated in China and selection of mcr-1 under cephalosporins pressure 猪源性大肠杆菌mcr-1与blaCTX-M的共存及头孢菌素压力下mcr-1的选择
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-04 DOI: 10.1016/j.jgar.2025.08.018
Zixian Wang , Lin Zheng , Lingwei Zhu , Jingyi Guo , Gejin Lu , Jie Jing , Shiwen Sun , Yang Sun , Xue Ji , Bowen Jiang , Bing Liang , Chuanfang Zhao , Xuejun Guo

Objectives

The usage of cephalosporins (CEFs) and the co-existence of the extended-spectrum β-lactamase gene blaCTX−M in the same host may promote the prevalence of the colistin (CST) resistance gene mcr-1. This study aims to investigate the underlying mechanisms of how the mcr-1 and blaCTX−M demonstrate significant co-occurrence in Escherichia coli (E. coli).

Methods

Conjugation assays were performed on 22 porcine-derived mcr-1-positive and blaCTX−M-positive E. coli (MCRPEC::blaCTX−M+) isolates from China to assess co-transfer potential. Whole-genome sequencing characterized the genetic localization and context of mcr-1 and blaCTX−M. Fitness cost and genetic stability were evaluated through the growth curve and antimicrobial resistance (AMR) gene stability rates measurements. Additionally, we examined mcr-1 selection during blaCTX−M co-existence under CEFs’ pressure by monitoring fitness and stability variations in mcr-1.

Results

Successful co-transfer of mcr-1 and blaCTX−M occurred in 36% (8/22) of isolates, demonstrating co-transfer efficiency ranging from 1.3 × 10–5 to 1.5 × 10–3. Predominant plasmid combinations facilitating co-transfer were the IncI2(mcr-1) + IncI1(blaCTX−M) combination. Notably, we report the first identification of blaCTX−M-positive E. coli (CTX-M-EC) carrying dual mcr-1 copies on plasmids. The mcr-1 and blaCTX−M did not exhibit fitness costs in 63% (5/8) of transconjugants, with 88% (7/8) maintaining over 70% stable rate in 10 d. CEFs’ pressure enhanced both the fitness and stability of mcr-1 in blaCTX−M co-harbouring transconjugants.

Conclusions

The observed high co-transfer efficiency, high stability rates, and low fitness costs of mcr-1 and blaCTX−M across distinct plasmid types and the mcr-1 selection driven by CEFs support the co-existence of mcr-1 and blaCTX−M in E. coli hosts. Our findings support the suggestion that there is an urgent need for coordinated antibiotic stewardship targeting both drug classes to curb multidrug-resistant (MDR) bacteria spread.
目的:头孢菌素(CEFs)的使用和广谱β-内酰胺酶(ESBL)基因blaCTX-M在同一宿主体内共存可能促进粘菌素(CST)耐药基因mcr-1的流行。本研究旨在探讨mcr-1和blaCTX-M在大肠杆菌中显著共存的潜在机制。方法:对22株猪源性mcr-1阳性和blaCTX-M阳性大肠杆菌(MCRPEC::blaCTX-M+)进行偶联试验,评估共转移潜力。全基因组测序鉴定了mcr-1和blaCTX-M的遗传定位和背景。通过生长曲线和抗菌素耐药性(AMR)基因稳定率的测定来评价适应度成本和遗传稳定性。此外,我们通过监测mcr-1的适应性和稳定性变化,研究了CEFs压力下blaCTX-M共存期间mcr-1的选择。结果:mcr-1与blaCTX-M共转移成功率为36%(8/22),共转移效率为1.3×10-5 ~ 1.5×10-3。促进共转移的主要质粒组合是IncI2(mcr-1) + IncI1(blaCTX-M)组合。值得注意的是,我们报告了首次鉴定的blactx - m阳性大肠杆菌(CTX-M-EC)在质粒上携带双mcr-1拷贝。63%(5/8)的转共轭体mcr-1和blaCTX-M不表现出适应成本,88%(7/8)的转共轭体在10天内保持70%以上的稳定率。CEFs压力增强了blaCTX-M共载转共轭子中mcr-1的适应性和稳定性。结论:观察到mcr-1和blaCTX-M在不同质粒类型间的高共转移效率、高稳定性和低适应成本,以及CEFs驱动的mcr-1选择支持mcr-1和blaCTX-M在大肠杆菌宿主中共存。我们的研究结果支持了一项建议,即迫切需要针对这两种药物进行协调的抗生素管理,以遏制多重耐药细菌的传播。
{"title":"Co-existence of mcr-1 and blaCTX−M from porcine-derived Escherichia coli isolated in China and selection of mcr-1 under cephalosporins pressure","authors":"Zixian Wang ,&nbsp;Lin Zheng ,&nbsp;Lingwei Zhu ,&nbsp;Jingyi Guo ,&nbsp;Gejin Lu ,&nbsp;Jie Jing ,&nbsp;Shiwen Sun ,&nbsp;Yang Sun ,&nbsp;Xue Ji ,&nbsp;Bowen Jiang ,&nbsp;Bing Liang ,&nbsp;Chuanfang Zhao ,&nbsp;Xuejun Guo","doi":"10.1016/j.jgar.2025.08.018","DOIUrl":"10.1016/j.jgar.2025.08.018","url":null,"abstract":"<div><h3>Objectives</h3><div>The usage of cephalosporins (CEFs) and the co-existence of the extended-spectrum β-lactamase gene <em>bla</em><sub>CTX−M</sub> in the same host may promote the prevalence of the colistin (CST) resistance gene <em>mcr-1</em>. This study aims to investigate the underlying mechanisms of how the <em>mcr-1</em> and <em>bla</em><sub>CTX−M</sub> demonstrate significant co-occurrence in <em>Escherichia coli</em> (<em>E. coli</em>).</div></div><div><h3>Methods</h3><div>Conjugation assays were performed on 22 porcine-derived <em>mcr-1</em>-positive and <em>bla</em><sub>CTX−M</sub>-positive <em>E. coli</em> (MCRPEC::<em>bla</em><sub>CTX−</sub><em><sub>M</sub></em><sup>+</sup>) isolates from China to assess co-transfer potential. Whole-genome sequencing characterized the genetic localization and context of <em>mcr-1</em> and <em>bla</em><sub>CTX−M</sub>. Fitness cost and genetic stability were evaluated through the growth curve and antimicrobial resistance (AMR) gene stability rates measurements. Additionally, we examined <em>mcr-1</em> selection during <em>bla</em><sub>CTX−M</sub> co-existence under CEFs’ pressure by monitoring fitness and stability variations in <em>mcr-1</em>.</div></div><div><h3>Results</h3><div>Successful co-transfer of <em>mcr-1</em> and <em>bla</em><sub>CTX−M</sub> occurred in 36% (8/22) of isolates, demonstrating co-transfer efficiency ranging from 1.3 × 10<sup>–5</sup> to 1.5 × 10<sup>–3</sup>. Predominant plasmid combinations facilitating co-transfer were the IncI2(<em>mcr-1</em>) + IncI1(<em>bla</em><sub>CTX−M</sub>) combination. Notably, we report the first identification of <em>bla</em><sub>CTX−M</sub>-positive <em>E. coli</em> (CTX-M-EC) carrying dual <em>mcr-1</em> copies on plasmids. The <em>mcr-1</em> and <em>bla</em><sub>CTX−M</sub> did not exhibit fitness costs in 63% (5/8) of transconjugants, with 88% (7/8) maintaining over 70% stable rate in 10 d. CEFs’ pressure enhanced both the fitness and stability of <em>mcr-1</em> in <em>bla</em><sub>CTX−M</sub> co-harbouring transconjugants.</div></div><div><h3>Conclusions</h3><div>The observed high co-transfer efficiency, high stability rates, and low fitness costs of <em>mcr-1</em> and <em>bla</em><sub>CTX−M</sub> across distinct plasmid types and the <em>mcr-1</em> selection driven by CEFs support the co-existence of <em>mcr-1</em> and <em>bla</em><sub>CTX−M</sub> in <em>E. coli</em> hosts. Our findings support the suggestion that there is an urgent need for coordinated antibiotic stewardship targeting both drug classes to curb multidrug-resistant (MDR) bacteria spread.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 164-172"},"PeriodicalIF":3.2,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dispensing of antibiotics without prescription in community drug retail outlets of Bahir Dar City in Northwest Ethiopia: A simulated client visit before and after educational intervention 埃塞俄比亚西北部巴希尔达尔市社区药品零售网点无处方分发抗生素:模拟客户访问前后的教育干预。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2025-09-04 DOI: 10.1016/j.jgar.2025.08.017
Masho Tigabe Tekle , Faisel Dula Sema , Minichil Chanie Worku , Abdisa Gemedi Jara , Worku Endalamaw Ayenew

Objectives

The non-prescription supply of antibiotics in community drug retail outlets (CDROs) significantly contributes to antibiotic resistance (ABR). This study aimed to assess the effectiveness of an educational intervention for pharmacy practitioners (PPs) in reducing over-the-counter (OTC) antibiotic sales.

Methods

From 1 August 2022, to 30 January 2023, a total of 80 simulated client (SC) visits (40 pre-intervention, 40:post-intervention) were made in 40 CDROs of Bahir Dar City, to determine the baseline and post-intervention extent of the OTC sale of antibiotics. Verbally a 30-minute one-time onsite education regarding antimicrobials, antibiotics, ABR, rational use of antibiotics, role of community PPs in ensuring rational use of antibiotics, and good antibiotic dispensing practice as an intervention was provided to 70 PPs who were working in the 40 CDROs. The education was guided by written informational material which was delivered to each PPs. Two months after the intervention, its effectiveness was tested using McNemar χ2 test, and a P value <0.05 was considered statistically significant.

Results

The intervention resulted in significant improvements in reducing non-prescription sale of antibiotics in CDROs (55 % pre-intervention vs. 20 % post-intervention), increasing the request for prescription paper (35 % vs. 75 %), insisting that antibiotics must be dispensed with prescription paper (33.3 % vs. 68.7 %), and reducing dispensing of antibiotics at level 1 demand (50 % vs. 25 %).

Conclusions

Educational intervention provided to PPs was effective in reducing the non-prescription sale of antibiotics, and it improved the practice of dispensing antibiotics.
目的:社区药品零售网点(CDROs)非处方抗生素供应对抗生素耐药(ABR)有显著影响。本研究旨在评估教育干预对药房从业人员(PPs)减少非处方(OTC)抗生素销售的有效性。方法:于2022年8月1日至2023年1月30日,对巴希尔达尔市40家cdro进行80次模拟客户(SC)访诊(干预前40次,干预后40次),确定抗生素OTC销售基线及干预后程度。对在40个CDROs工作的70名pp进行了30分钟的现场口头教育,内容包括抗菌剂、抗生素、ABR、抗生素合理使用、社区pp在确保抗生素合理使用中的作用以及良好的抗生素配药规范(GADP)作为干预措施。教育工作由一份书面信息材料指导,该材料已分发给每个pp。干预2个月后,采用McNemar卡方检验进行有效性检验,p值< 0.05为差异有统计学意义。结果:干预显著改善;减少cdro中抗生素的非处方销售(干预前55% Vs干预后20%),增加处方纸的需求(35% Vs 75%),坚持抗生素必须配处方纸分发(33.3% Vs 68.7%),并减少一级需求抗生素的分发(50% Vs 25%)。结论:对PPs进行教育干预可有效减少非处方销售抗菌药物,提高抗菌药物调剂工作质量。
{"title":"Dispensing of antibiotics without prescription in community drug retail outlets of Bahir Dar City in Northwest Ethiopia: A simulated client visit before and after educational intervention","authors":"Masho Tigabe Tekle ,&nbsp;Faisel Dula Sema ,&nbsp;Minichil Chanie Worku ,&nbsp;Abdisa Gemedi Jara ,&nbsp;Worku Endalamaw Ayenew","doi":"10.1016/j.jgar.2025.08.017","DOIUrl":"10.1016/j.jgar.2025.08.017","url":null,"abstract":"<div><h3>Objectives</h3><div>The non-prescription supply of antibiotics in community drug retail outlets (CDROs) significantly contributes to antibiotic resistance (ABR). This study aimed to assess the effectiveness of an educational intervention for pharmacy practitioners (PPs) in reducing over-the-counter (OTC) antibiotic sales.</div></div><div><h3>Methods</h3><div>From 1 August 2022, to 30 January 2023, a total of 80 simulated client (SC) visits (40 pre-intervention, 40:post-intervention) were made in 40 CDROs of Bahir Dar City, to determine the baseline and post-intervention extent of the OTC sale of antibiotics. Verbally a 30-minute one-time onsite education regarding antimicrobials, antibiotics, ABR, rational use of antibiotics, role of community PPs in ensuring rational use of antibiotics, and good antibiotic dispensing practice as an intervention was provided to 70 PPs who were working in the 40 CDROs. The education was guided by written informational material which was delivered to each PPs. Two months after the intervention, its effectiveness was tested using McNemar χ<sup>2</sup> test, and a <em>P</em> value &lt;0.05 was considered statistically significant.</div></div><div><h3>Results</h3><div>The intervention resulted in significant improvements in reducing non-prescription sale of antibiotics in CDROs (55 % pre-intervention vs. 20 % post-intervention), increasing the request for prescription paper (35 % vs. 75 %), insisting that antibiotics must be dispensed with prescription paper (33.3 % vs. 68.7 %), and reducing dispensing of antibiotics at level 1 demand (50 % vs. 25 %).</div></div><div><h3>Conclusions</h3><div>Educational intervention provided to PPs was effective in reducing the non-prescription sale of antibiotics, and it improved the practice of dispensing antibiotics.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"45 ","pages":"Pages 138-146"},"PeriodicalIF":3.2,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of global antimicrobial resistance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1